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Matrikines are key regulators in modulating
the amplitude of lung inﬂammation in acute
pulmonary infection
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Bioactive matrix fragments (matrikines) have been identiﬁed in a myriad of disorders, but
their impact on the evolution of airway inﬂammation has not been demonstrated. We recently
described a pathway where the matrikine and neutrophil chemoattractant proline–
glycine–proline (PGP) could be degraded by the enzyme leukotriene A4 hydrolase (LTA4H).
LTA4H classically functions in the generation of pro-inﬂammatory leukotriene B4, thus LTA4H
exhibits opposing pro- and anti-inﬂammatory activities. The physiological signiﬁcance of
this secondary anti-inﬂammatory activity remains unknown. Here we show, using readily
resolving pulmonary inﬂammation models, that loss of this secondary activity leads to more
pronounced and sustained inﬂammation and illness owing to PGP accumulation. PGP elicits
an exacerbated neutrophilic inﬂammation and protease imbalance that further degrades the
extracellular matrix, generating fragments that perpetuate inﬂammation. This highlights a
critical role for the secondary anti-inﬂammatory activity of LTA4H and thus has consequences
for the generation of global LTA4H inhibitors currently being developed.
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N
eutrophils are critical components of the body’s immune
response, being readily mobilized to the site of infection
and destroying invading micro-organisms1,2. Recruitment
of neutrophils into the tissue in response to infection is
mediated by an array of chemoattractant signals, including lipid
molecules such as leukotriene B4 (LTB4) and the glutamic
acid–leucine–arginineþ (ELRþ ) class of chemokines. ELRþ
chemokines, including interleukin (IL)-8 in humans and KC
and MIP-2 in mice, exert their activity by binding to receptors
CXCR1/2 (ref. 3). Despite their clear antimicrobial capacity,
neutrophils are not indiscriminate killers but their inﬂammation
is tightly regulated and they are able to elegantly and speciﬁcally
shape many facets of the elicited immune response4,5. However,
owing to their potent arsenal, an over-exuberant or persistent
neutrophilic inﬂammation is implicated in the pathologies of
chronic diseases such as chronic obstructive pulmonary disease
(COPD) and cystic ﬁbrosis (CF)6,7.
A protease–antiprotease imbalance is a hallmark of many
chronic lung diseases, with the presence and activity of several
matrix metalloproteinases (MMPs) and neutrophil elastase (NE),
in particular, correlating with COPD pathology. Such proteases
target the extracellular matrix (ECM) for degradation, disrupting
tissue architecture and releasing ECM-derived chemoattractant
signals, termed ‘matrikines’, which can perpetuate inﬂammation8.
Models of exposure to cigarette smoke show that both
breakdown of ECM (by neutrophil or macrophage elastase) and
accumulation of neutrophils are required for pathological
changes9–12. It is plausible therefore that a protease-/matrikine-
driven inﬂammation may underlie the pathology observed in
such chronic diseases.
The tripeptide proline–glycine–proline (PGP) is one such
matrikine, being a neutrophil chemoattractant derived from ECM
collagen that exerts its activity by mimicking key sequences found
in ELRþ chemokines and binding to CXCR1/2 (ref. 13). PGP is
generated from collagen via the sequential enzymatic activity of
MMPs (speciﬁcally MMP-8 and -9) and prolylendopeptidase
(PE)14. Signiﬁcant quantities of PGP are found in patients with
chronic lung diseases such as COPD, CF and bronchiolitis
obliterans syndrome14–18. Recently, we have identiﬁed a novel
anti-inﬂammatory pathway whereby PGP is readily degraded
by the extracellular activity of the enzyme leukotriene A4
hydrolase (LTA4H)19. We subsequently demonstrated that
this LTA4H-mediated PGP degradation is perturbed by
cigarette smoke, contributing to the accumulation of PGP in
COPD18,19.
LTA4H is classically recognized for its intracellular epoxide
hydrolase activity, whereby it generates the pro-inﬂammatory
lipid mediator LTB4 (refs 20,21). LTB4 may bind to receptors
BLT1 or BLT2; while BLT1 is a high-afﬁnity and speciﬁc
receptor for LTB4, BLT2 binds LTB4 with substantially lower
afﬁnity and can also bind to other eicosanoids22. The
physiological functions of LTB4 are attributed to signalling
through BLT1. LTB4 can drive the recruitment and activation of
an array of cells including neutrophils and is thus implicated in
protection against invading micro-organisms but also in the
pathology of an array of diseases23–27. Thus, LTA4H represents
an unusual enzyme with opposing pro- and anti-inﬂammatory
activities that dictate the amplitude and persistence of
neutrophilic inﬂammation28. There has been signiﬁcant interest
from pharmaceutical companies to target LTA4H therapeutically
to alleviate LTB4-mediated pathologies, but despite the generation
of several excellent inhibitors, these drugs have failed to
demonstrate clinical efﬁcacy29,30. The lack of success of these
compounds could feasibly be due to their failure to distinguish
between the opposing roles of LTA4H and thus inadvertently
prevent PGP degradation.
The critical role of LTA4H in generating LTB4 and the
signiﬁcance of this lipid mediator in multiple inﬂammatory
settings are undeniable. While it is clear that LTA4H possesses a
secondary anti-inﬂammatory role in degrading PGP, the relative
physiological signiﬁcance of this activity remains unclear.
To address this, we have manipulated the LTA4H pathways in
a murine model of Haemophilus inﬂuenzae b (Hib). H. inﬂuenzae
is a Gram-negative coccobacillus, of which there are encapsulated
and unencapsulated strains31,32. Unencapsulated strains are
termed non-typeable (NTHI) and are frequent causes of
exacerbations of COPD and asthma. Encapsulated strains are
divided into serotypes, of which there are six (a–f), based on their
capsular antigen. Serotype B (Hib) is the cause of most invasive
H. inﬂuenzae infections, which include pneumonia, meningitis,
septicaemia and epiglottitis33. However, in most people Hib is
found as a commensal of the nasopharynx, with the bacteria
becoming invasive in only a small number of cases.
The murine model of Hib infection was chosen to dissect the
dual activities of LTA4H, as it represents a non-complicated
infection whereby the pathogen is readily cleared but elicits a
robust pulmonary neutrophilia that is rapidly resolved. In this
setting, it is feasible to address whether a failure to degrade PGP
can lead to an augmented and prolonged neutrophilia to what is a
relatively innocuous pulmonary insult. It thus provides an ideal
model to probe the relative roles of LTB4 and PGP in protection
and pathology. In this context, LTB4 was shown to be critical to
bacterial phagocytosis and killing on a per-cell basis, but did not
control the magnitude of the inﬂammatory response or illness.
Conversely, a failure of LTA4H-mediated degradation of PGP led
to accumulation of the peptide and a marked augmentation in
inﬂammation and illness. This manifested primarily as a
PGP-mediated increase in neutrophil numbers in the lung and
airways, and a secondary protease imbalance that resulted in
generation of elastin-derived matrikines that promoted a
secondary macrophage inﬁltrate. Thus the failure to degrade
PGP can have signiﬁcant deleterious consequences, highlighting
the key physiological role of the secondary anti-inﬂammatory
activity of LTA4H and the prominent pathological role of PGP in
inducing a general protease–matrikine imbalance.
Results
Dual-LTA4H activities are functional during Hib infection.
Infection of 129/S6 mice with Hib elicited a transient, mild weight
loss peaking at 24–48 h post infection, which correlated with the
size of the inoculating dose of bacteria (Fig. 1a). Coinciding with
peak illness was a robust, readily resolving inﬂammation observed
in the airways (Fig. 1b) and lungs (Fig. 1c). Consequently,
bacteria were promptly cleared from the airways (Fig. 1d) and
lung parenchyma (Fig. 1e) of infected mice. The pulmonary
inﬁltrate was predominantly neutrophilic, with Hib inducing a
rapid, dose-dependent, inﬂux of neutrophils peaking at 24 h post
infection (Fig. 1f,g). Secondary to this neutrophilic inﬂammation
was a relatively modest inﬁltration of monocytes/macrophages,
natural killer cells and T cells (Supplementary Fig. 1A–E,
respectively). Within this system, alveolar macrophages
(Supplementary Fig. 1F–H) and neutrophils (Fig. 1h,i) were
critical to the clearance of Hib, as their depletion signiﬁcantly
compromised bacterial clearance.
The arrival of neutrophils into the lungs and airways of Hib-
infected mice was preceded by the release of ELRþ CXC
chemokines KC (Fig. 1j) and MIP-2 (Fig. 1k) into the
bronchoalveolar lavage ﬂuid (BALF). Furthermore, conventional
intracellular epoxide hydrolase activity of LTA4H was augmented
by infection (Fig. 1l) and the neutrophil chemoattractant LTB4 was
released into the BALF (Fig. 1m). This elevation in epoxide
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hydrolase activity of LTA4H was seemingly attributable to the
substantial neutrophilic inﬁltrate, with the activity markedly
reduced following neutrophil depletion (Fig. 1n). Key PGP-
generating enzymes MMP-9 (Fig. 1o,p) and PE (Fig. 1q) were
induced by Hib infection, but PGP was undetectable at any time
point. Neutrophils are a prominent source of these
PGP-generating enzymes enabling a feed-forward vicious circle
of neutrophilic inﬂammation14,19,34–36. Accordingly, neutrophil
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Figure 1 | Dual-LTA4H activities are functional during Hib infection. 129/S6 mice were infected with Hib and weight loss assessed daily (a). Total cell
numbers in the airways (b) and lung tissue (c) of Hib-infected mice were measured. Bacterial burden was assessed by performing serial dilutions of BALF
(d) and lung homogenate (e) on Brain Heart Infusion agar. The number of neutrophils recruited into the airways (f) and lung tissue (g) of Hib-infected mice
was determined by ﬂow cytometry. Mice infected with 1 107 Hib were administered control (2A3) or neutrophil-depleting (1A8) antibody, and neutrophil
numbers (h) and c.f.u. (i) were assessed at 24h post infection. The concentration of KC (j) and MIP-2 (k) in the BALF was determined by ELISA. Intracellular
epoxide hydrolase activity of BAL cells (l). LTB4 levels in BALF of Hib-infected mice (m). Mice infected with 1 107 Hib were administered 2A3 or 1A8
antibody and intracellular epoxide hydrolase activity of BAL cells determined at 24h post infection (n). Amounts of total MMP-9 (o) in BALF were assessed by
ELISA and MMP-9 gelatinolytic activity (p) was assessed by gelatin zymography (representative image depicted: lane 1¼ naive; 2¼ 1 106 6 h; 3¼ 1 107
6 h; 4¼ 1 106 24h; 5¼ 1 107 24h; 6¼ 1 106 day 3; 7¼ 1 107 day 3; 8¼ 1 106 day 7; 9¼ 1 107 day 7). (q) PE activity in BALF at different times after
Hib infection. Mice infected with 1 107 Hib were administered 2A3 or 1A8 antibody, and total MMP-9 levels (r) and PE activity (s) in the BALF were
determined at 24h post infection. Total LTA4H levels in BALF were assessed by ELISA at different times post infection (t). BALF, from different time points
post Hib infection, was incubated with PGP and degradation was assessed after 2 h by mass spectrometry (u) or release of free proline (v). Mice infected with
1 107 Hib were administered 2A3 or 1A8 antibody and PGP degradation by BALF at 24h was assessed by mass spectrometry (w) or release of free proline
(x). Data (mean±s.e.m.) are representative of at least two experiments with 5–6 mice per group.*Po0.05; **Po0.01 using the Mann–Whitney test.
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depletion in Hib-infected mice resulted in a signiﬁcant reduction in
BALF MMP-9 levels (Fig. 1r) and PE activity (Fig. 1s). The failure
to detect PGP, despite the presence of MMP-9/PE, could be
attributable to extracellular release of LTA4H (Fig. 1t) and its
capacity to degrade PGP (Fig. 1u,v). As previously postulated19,
neutrophils are likely a source of extracellular LTA4H, as their
depletion resulted in reduced capacity of BALF to degrade
PGP (Fig. 1w,x). Thus both the pro-inﬂammatory
LTB4-generating and the anti-inﬂammatory PGP-degrading
activities of LTA4H are operational within this acute pulmonary
neutrophilia model. The nature of this elicited response to Hib
observed in 129/S6 mice was comparable in Balb/c and C57BL/6
mice (Supplementary Fig. 2).
Loss of LTB4 signalling compromises Hib clearance. Physiolo-
gical functions attributed to LTB4 are relayed through receptor
BLT1. To infer the role of LTB4 in our Hib model, wild-type
(WT) and blt1 / mice were infected with 1 107
colony-forming unit (c.f.u.) of Hib. WT and blt1 / mice
displayed comparable weight loss (Fig. 2a) and inﬂammation into
the airways (Fig. 2b) and lung parenchyma (Fig. 2c) in response
to Hib. Speciﬁcally, neutrophilic inﬂammation into the airways
(Fig. 2d) and lung tissue (Fig. 2e) was indistinguishable
between Hib-infected WT and blt1 / mice. Despite
comparable cellular inﬂammation, clearance of Hib was
compromised in blt1 / mice at 6 (Fig. 2f) and 24 h (Fig. 2g)
post infection. A plethora of studies have highlighted the capacity
of LTB4 to augment the phagocytic and antimicrobial potential of
macrophages and neutrophils on a per-cell basis26,37–50. Alveolar
macrophages (Fig. 2h) and neutrophils (Fig. 2i) from blt1 /
mice exhibited a signiﬁcant reduction in their capacity to
phagocytose pHrodo-labelled Hib relative to WT controls.
Furthermore, blt1 / alveolar macrophages (Fig. 2j) and
neutrophils (Fig. 2k) exhibited reduced bacterial killing of Hib
on a per-cell basis relative to WT counterparts.
The comparable cellular inﬂammation but compromised
bacterial clearance observed at 24 h post infection in Hib-infected
blt1 / mice relative to WT controls was recapitulated
through administration of a BLT-1-speciﬁc antagonist U-75302
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Figure 2 | An absence of LTB4 signalling does not alter pulmonary inﬂammation but compromises bacterial clearance. Blt1 / mice and WTcontrols
were infected intranasally with 1 107 Hib and weight loss was assessed daily and expressed as a percentage of the original body mass (a). Total cell
numbers in the airways (b) and lung tissue (c) of Hib-infected mice were enumerated. The number of neutrophils recruited into the airways (d) and lung
tissue (e) of Hib-infected mice was determined by ﬂow cytometry. Bacterial burden was assessed by performing serial dilutions of BALF and lung
homogenate, at 6 h (f) and 24 h (g), on Brain Heart Infusion (BHI) agar plates. Phagocytosis of pHrodo-conjugated Hib by alveolar macrophages (h) and
neutrophils (i) was assessed by ﬂow cytometry. The capacity of WTand blt1 / alveolar macrophages (j) and neutrophils (k) to kill Hib was assessed.
Hib-infected mice were administered vehicle (PBS), BLT1 antagonist (U-75302) or BLT2 antagonist (LY2552833), and lung neutrophil numbers (l) and c.f.u.
(m) were assessed at 24 h post infection. Data (mean±s.e.m.) are representative of at least two experiments with 5–6 mice per group. *Po0.05;
**Po0.01 using the Mann–Whitney test.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9423
4 NATURE COMMUNICATIONS | 6:8423 | DOI: 10.1038/ncomms9423 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
to Hib-infected WT mice (Fig. 2l,m). Administration of a
preferential BLT2 antagonist LY2552833 to Hib-infected WT
mice had no effect on cellular inﬂammation or bacterial clearance
(Fig. 2l,m), suggesting that BLT2 is not important in regulating
these parameters within this model.
The enzyme 5-lipoxygenase (5-LO) generates leukotriene A4
(LTA4), which is subsequently hydrolysed by LTA4H into LTB4
(Supplementary Fig. 3A). To further verify the role of LTB4 in the
outcome of Hib infection, we administered the 5-LO inhibitor
zileuton to infected animals. While zileuton will inhibit LTB4
formation, there is the caveat that it could also disrupt production
of cysteinyl leukotrienes (LTC4, D4, E4) and lipoxins since they
share a common LTA4 intermediate (Supplementary Fig. 3A).
Zileuton-administered Hib-infected mice showed comparable
cellular inﬂammation into the airways and lungs at 24 h
(Supplementary Fig. 3B,C) relative to control-treated animals.
Furthermore, zileuton administration did not alter neutrophil
numbers (Supplementary Fig. 3D,E) but did compromise
bacterial clearance (Supplementary Fig. 3F,G).
Hib-infected lta4h / mice display augmented inﬂammation.
Having inferred the role of LTB4 in Hib infection, it was now of
interest to determine the phenotype of Hib-infected lta4h /
mice that lack not only the classical pro-inﬂammatory LTB4-gen-
erating activity but also the anti-inﬂammatory PGP-degrading
activity. WT and lta4h / mice were infected with 1 107 c.f.u.
of Hib and ensuing illness and inﬂammation assessed. Hib-infected
lta4h / mice exhibited a more pronounced weight loss
that was slower to resolve relative to WT controls (Fig. 3a).
In keeping with a more pronounced illness in lta4h / mice,
they also displayed augmented pulmonary oedema (Fig. 3b)
and cellular damage (Fig. 3c). The more pronounced
illness observed in Hib-infected lta4h / mice relative to
WT controls was not attributable to compromised bacterial
clearance, as c.f.u. were comparable in BALF (Fig. 3d) and lung
parenchyma (Fig. 3e). Instead, Hib-infected lta4h / mice
showed a marked increase in cellular inﬁltrate into their airways
(Fig. 3f) and lung tissue (Fig. 3g) relative to the WT animals, which
was largely attributable to a substantial increase in neutrophils
(Fig. 3h,i). Secondary to the augmented neutrophilia seen in
lta4h / mice was an elevated inﬁltration of monocytes/mac-
rophages into the airways (Fig. 3j) and lung tissue (Fig. 3k) relative
to WT controls.
PGP drives an exacerbated neutrophilic inﬂammation to Hib.
The augmented neutrophilic inﬂammation observed in
Hib-infected lta4h / mice, despite the absence of LTB4
(Fig. 4a), was not attributable to an elevation in KC and MIP-2
since levels in BALF (Fig. 4b,c) were comparable between WT
and lta4h / mice. Other neutrophil chemoattractants C5a,
lungkine/CXCL15 and ENA-78/CXCL5 were also comparable
between WT and lta4h / mice (Supplementary Fig. 4A–C).
Levels of pro-inﬂammatory cytokines tumour-necrosis factor
(TNF)-a (Fig. 4d) and IL-6 (Fig. 4e), which can regulate
neutrophil recruitment, were elevated at 24 h in Hib-infected
lta4h / mice, but seemed insufﬁcient alone to drive the
observed phenotype. However, while no PGP was detectable in
the BALF of Hib-infected WT mice, signiﬁcant quantities were
present in lta4h / animals (Fig. 4f). Accordingly, the capacity
of BALF to degrade PGP was absent in Hib-infected lta4h /
mice (Fig. 4g,h). PGP administration to Hib-infected WT mice
augmented airway neutrophilia (Fig. 4i) and promoted bacterial
clearance (Fig. 4j), supporting the notion that the phenotype of
the lta4h / animals could be attributable to PGP
accumulation.
To verify that the exacerbated illness and neutrophilic
inﬂammation observed in lta4h / mice was due to
PGP accumulation, we utilized a complementary peptide that
speciﬁcally antagonizes PGP, namely arginine–threonine–
arginine (RTR)36,51. Hib-infected WT and lta4h / mice
were administered RTR, and inﬂammation and bacterial burden
were assessed at 24 h post infection. While WT mice again
displayed no PGP in their airways, control and RTR-treated
lta4h / mice exhibited substantial quantities, highlighting
that RTR does not reduce levels of PGP but rather binds and
antagonizes it (Fig. 4k)52. Administration of RTR to Hib-infected
lta4h / mice completely negated the augmented cellular
inﬁltrate seen in the airways (Fig. 4l) and lungs (Fig. 4m) of these
mice above that observed in the WT controls. Furthermore,
administration of RTR to lta4h / mice compromised
bacterial clearance (Fig. 4n)—presumably due to the loss of
LTB4 and now the compensatory PGP that had previously
conferred some augmented protection. In keeping with the role of
PGP, the reduction in pulmonary inﬂammation observed in Hib-
infected lta4h / mice administered RTR was due to a
diminished neutrophilic inﬁltrate (Fig. 4o,p). The previously
observed heightened TNF-a and IL-6 release in Hib-infected
lta4h / mice (Fig. 4d,e) was normalized to WT levels
following RTR treatment (Fig. 4q,r), suggestive that it is
secondary to PGP. As a point of note, it has been suggested
that loss of LTA4H function can lead to an accumulation
of LTA4 and a subsequent lipoxin shunt, whereby levels
of anti-inﬂammatory lipoxins are increased53. If this were the
case in Hib-infected lta4h / mice, then one may envisage a
reduced inﬂammation in response to the bacteria rather than
the substantial PGP-driven increase observed. Furthermore,
within our model system no lipoxins were detectable at any
time point.
Greater monocyte inﬂux in Hib-infected lta4h / mice. PGP
is a neutrophil chemoattractant and thus while it is rational that a
greater neutrophil inﬁltrate is observed in lta4h / mice infected
with Hib, it cannot explain the augmented ensuing inﬁltration of
monocytes (Fig. 3j,k). Furthermore, there were comparable levels of
classical monocyte-attracting chemokines preceding this monocytic
inﬁltrate in lta4h / mice and littermate controls (Supplemen-
tary Fig. 4D–G). While collagen-derived PGP is not chemotactic for
monocytes, elastin-derived matrikines are11,54,55. It was postulated
that PGP accumulation in lta4h / mice may drive augmented
neutrophilic inﬂammation with ensuing augmented elastase activity,
elastin fragment generation and monocyte inﬁltration—in essence a
protease/matrikine-driven inﬂammatory exacerbation.
In keeping with elevated neutrophilic inﬂammation in
Hib-infected lta4h / mice, there was a signiﬁcant increase
in BALF levels of neutrophil-rich proteases MMP-9 (Fig. 5a)
and NE (Fig. 5b). Furthermore, there was an augmentation in
MMP-9 messenger RNA (mRNA) reﬂective of the substantial
inﬂux of neutrophils richly expressing this protease (Fig. 5c).
Stimulation of bone marrow neutrophils with PGP elicited
the release of MMP-9 and NE (Fig. 5d), demonstrating that
the peptide was not only capable of recruiting neutrophils but
also driving the secretion of their products. Intriguingly,
Hib-infected lta4h / mice also displayed elevated
macrophage elastase, MMP-12, levels in BALF (Fig. 5e).
MMP-12 is predominantly expressed by alveolar macrophages
and not neutrophils. There was no difference in MMP-12 mRNA
levels between lta4h / mice and littermate controls (Fig. 5f),
suggestive that increased levels in the BALF of knockout animals
was not due to increased expression but rather release from
alveolar macrophages.
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was determined by ﬂow cytometry. Data (mean±s.e.m.) are combined from two separate experiments with 4–5 mice per group and are representative of
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NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9423 ARTICLE
NATURE COMMUNICATIONS | 6:8423 | DOI: 10.1038/ncomms9423 | www.nature.com/naturecommunications 7
& 2015 Macmillan Publishers Limited. All rights reserved.
In keeping with a blunted PGP-driven neutrophilic
inﬂammation in RTR-treated lta4h / mice, there was a
concomitant reduction in BALF MMP-9 (Fig. 5g) and NE
levels were trending down (P¼ 0.1; Fig. 5h). Furthermore, BALF
levels of MMP-12 (Fig. 5i) were reduced, conﬁrming that
augmented levels in lta4h / animals were secondary to PGP
accumulation. NE and MMP-12 can target elastin to generate
fragments that are chemotactic for monocytes and could underlie
their augmented numbers in Hib-infected lta4h / mice. To
verify this, Hib-infected WT and lta4h / mice were treated
with BA4 antibody (demonstrated to neutralize chemotactic
elastin fragments), and cellular inﬁltrate assessed at day 4 post
infection. BA4 administration to Hib-infected lta4h / mice
blunted the elevated cellular inﬁltrate observed in airways (Fig. 5j)
and lungs (Fig. 5k) of these animals and was largely attributable
to a reduction in numbers of monocytes/macrophages (Fig. 5l,m).
S. pneumoniae infection of lta4h / mice. To demonstrate
that the exacerbated inﬂammation seen in Hib-infected
lta4h / mice is not speciﬁc to a single model system, we
investigated the dual roles of the enzyme following pulmonary
infection with the Gram-positive bacteria Streptococcus pneumo-
niae. Infection of 129/S6 mice with S. pneumoniae elicited an early
weight loss that correlated with size of the inoculating dose of
bacteria (Supplementary Fig. 5A). However, unlike with Hib
infection, bacterial burden is not efﬁciently eradicated from the
airways or lung tissue (Supplementary Fig. 5B,C). Coinciding with
the early weight loss was a robust inﬂammation in the airways
(Supplementary Fig. 5D) and lung tissue (Supplementary Fig. 5E)
that was again predominantly neutrophilic (Supplementary
Fig. 5F,G). Key PGP-generating enzymes MMP-9 (Supplemen-
tary Fig. 5H) and PE (Supplementary Fig. 5I) were readily induced
by S. pneumoniae infection, but PGP was undetectable at any time
point by mass spectrometry. The failure to detect PGP, despite the
presence of MMP-9/PE, was again attributable to extracellular
release of LTA4H and its capacity to degrade PGP (Supplementary
Fig. 5J).
WT and lta4h / mice were infected with either 1 105 or
1 106 c.f.u. of S. pneumoniae, and inﬂammation was assessed
24 h later. Lta4h / mice displayed a signiﬁcant increase in
cellular inﬁltrate into their airways (Supplementary Fig. 5K) with
both doses of bacteria relative to littermate controls, which was
largely attributable to a substantial increase in neutrophils
(Supplementary Fig. 5L). The augmented neutrophilic inﬁltrate
in S. pneumoniae-infected lta4h / mice relative to controls
was not attributable to compromised bacterial clearance
(Supplementary Fig. 5M) but rather to an accumulation of PGP
(Supplementary Fig. 5N).
Discussion
LTA4H is the rate-limiting enzyme in LTB4 biosynthesis, a potent
pro-inﬂammatory mediator implicated in host defence but also
an array of pathological conditions. However, we have recently
identiﬁed a novel anti-inﬂammatory role for LTA4H in degrading
the neutrophil chemoattractant PGP19. The physiological
signiﬁcance of this secondary PGP-degrading activity of LTA4H
has not been addressed, and it is unknown whether a failure to
degrade PGP can lead to adverse pathological sequelae, despite
the absence of LTB4. To investigate the dual roles of LTA4H, we
have primarily utilized an acute lung injury model of Hib
infection—a model chosen since it evokes a robust pulmonary
neutrophilia, but both inﬂammation and infection are readily
resolved without complication. In this setting, it is feasible to
assess the signiﬁcance and risks of failing to degrade PGP and
infer the importance of both LTA4H activities in protection and
pathology.
Hib infection of WT mice resulted in an acute pulmonary
neutrophilia that, together with resident alveolar macrophages, was
important for the efﬁcient clearance of bacteria. Concomitant with
this early inﬂammation was induction of the classical intracellular
epoxide hydrolase activity of LTA4H and release of LTB4, with
neutrophils themselves seemingly the prominent source of the
LTB4. Also concurrent with the pulmonary neutrophilic inﬂam-
mation was an increase in levels of key PGP-generating enzymes
MMP-9 and PE. Neutrophils are a prominent source of MMP-9
and PE and are thus capable of generating PGP and promoting
their own recruitment and eliciting a vicious cycle of pathology if
left unchecked14,19,34–36. However, despite the robust induction of
MMP-9 and PE in response to Hib, no PGP was detectable at any
time post infection. This was attributable to the extracellular
release of LTA4H and its potent anti-inﬂammatory PGP-degrading
capacity; thus both LTA4H activities are operational in our model
system. We also report a failure to detect PGP, despite the presence
of PGP-generating enzymes, in models of S. pneumoniae and
inﬂuenza infection19. We would now argue that PGP degradation
by LTA4H is the norm in settings of acute neutrophilia and
instrumental in the efﬁcient resolution of inﬂammation.
LTA4H is classically a cytosolic enzyme, but to perform its
PGP-degrading activity it must be released to an extracellular
environment. LTA4H is reported to exhibit wide tissue and
cellular distribution56, which has been difﬁcult to rationalize since
leukocytes are the only cells to express both LTA4H and 5-LO
required for leukotriene biosynthesis. It is feasible that the
capacity of LTA4H to degrade PGP may account for the
disproportionate distribution of LTA4H and 5-LO. We have
previously demonstrated epithelial cells and neutrophils to be
prominent sources of extracellular LTA4H19. Accordingly, we
report a reduction in extracellular LTA4H in neutrophil-depleted
Hib-infected mice. Thus neutrophils are capable of both initiating
and resolving their own inﬂammation through the action of
LTA4H, in disparate cellular locations.
Loss of LTB4 signalling through the use of blt1 / mice or
BLT1 antagonists, or administration of 5-LO inhibitor
zileuton, did not alter pulmonary inﬂammation or illness in
Figure 5 | Augmented macrophage inﬂammation in Hib-infected lta4h / mice secondary to PGP accumulation and protease discord. Lta4h /
mice and littermate controls were infected intranasally with 1 107 Hib and levels of total MMP-9 (a) and NE (b) were assessed by ELISA in the BALF.
Levels of MMP-9 mRNA were assessed in lung tissue by real-time PCR (c). Bone marrow neutrophils were incubated with media alone, IL-8 or AcPGP, and
levels of MMP-9 and NE were assessed in the supernatant after 15min (d). Levels of MMP-12 protein in the BALF were assessed by ELISA (e) and MMP-12
mRNA levels in lung tissue assessed by real-time PCR (f). Lta4h / mice and littermate controls infected intranasally with 1 107 Hib were
administered vehicle or RTR peptide, and the concentration of MMP-9 (g), NE (h) and MMP-12 (i) in the BALF was determined by ELISA at 24 h post
infection. To determine the role of elastin-derived chemotactic fragments in driving cellular recruitment, lta4h / mice and littermate controls infected
intranasally with 1 107 Hib were administered control or BA4 (anti-elastin) antibody, and total cell numbers in the airways (j) and lung tissue (k)
enumerated at 4 days post infection. In the same experiment, the numbers of inﬁltrating monocytes/macrophages in the airways (l) and lung tissue (m)
was determined by ﬂow cytometry at 4 days post infection. Data (mean±s.e.m.) are combined from two separate experiments with 4–5 mice per group
and are representative of 3–4 experiments (a,b,e) or are representative of at least two experiments with 5–6 mice per group (g–m). Data (mean±s.d.) are
representative of three experiments with at least triplicates (d). *Po0.05; **Po0.01 using the Mann–Whitney test.
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response to Hib infection, but signiﬁcantly compromised
bacterial clearance. The reduced capacity to control Hib
infection in blt1 / mice was attributable to reduced
phagocytosis and killing of the bacteria on a per-cell basis
by alveolar macrophages and neutrophils. A clear role for LTB4
in augmenting phagocytosis and microbicidal activity of
macrophages and neutrophils is well established26,37–50,
with the plethora of studies pertaining to Gram-negative
bacteria, Klebsiella pneumoniae, particularly pertinent to our
studies26,37,39,44,45.
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Given the potent pro-inﬂammatory capacity of LTB4, it seems
counterintuitive that there is not a reduced cellular inﬁltrate in
blt1 / mice or mice administered 5-LO inhibitor zileuton.
However, it is interesting to note that reduced neutrophil
recruitment to sites of inﬂammation in 5-LO / mice has
been observed in some, but certainly not all, experimental models
examined27,57. Indeed, a compromised pathogen clearance yet
comparable cellular inﬂammation has been reported previously in
mice with a disrupted LTB4 pathway26,42. Thus it may be that
while LTB4 serves an important function in Hib killing on a
per-cell basis, it is not critical for directing cellular inﬂammation
within this model, potentially owing to redundancy with other
neutrophil chemoattractants. Alternatively, it is feasible that an
absence of LTB4 signalling reduces cellular inﬂammation and
bacterial clearance, and this augmented TLR burden subsequently
yields a greater release of conventional neutrophil chemokines
that promote further neutrophil recruitment—thus masking the
original deﬁcit.
Lta4h / mice administered Hib displayed greater illness,
which was attributable to an augmented cellular inﬁltrate and
ensuing immunopathological sequelae. Most notable within this
phenotype was the striking increase in neutrophilic inﬂammation
of Hib-infected lta4h / mice, despite the loss of LTB4, and
comparable levels of other classical neutrophil chemoattractants.
This augmented neutrophilia was attributable to PGP accumula-
tion in lta4h / mice, as neutralization of PGP completely
ablated neutrophil inﬁltrate to WT levels. Levels of TNF-a and
IL-6, which could regulate neutrophilic inﬂammation and illness,
were also elevated in lta4h / mice, but were secondary to
PGP accumulation. Thus we show that a failure to degrade
PGP has serious implications in the control of neutrophilic
inﬂammation, and that the anti-inﬂammatory activity of LTA4H
has a clear physiological signiﬁcance over and above that of its
pro-inﬂammatory action in this setting.
It is perhaps surprising that, despite the clear role of LTB4 in
protection against Hib infection, lta4h / mice (which lack
LTB4) displayed a comparable bacterial burden to their littermate
controls. However, while lta4h / mice lack LTB4, they possess
an increase in PGP and ensuing neutrophilic inﬂammation that
seemingly compensates in vivo. Neutrophils are critical effector
cells within our Hib model and given the capacity of PGP to drive
neutrophil recruitment and effector function, it is not surprising
that PGP can prove protective against bacterial challenge, as
highlighted by a previous study58. Indeed, we demonstrate that
PGP administration to Hib-infected WT mice enhances
neutrophilic recruitment and bacterial clearance. Furthermore, we
clearly demonstrate that PGP is compensating for the loss of LTB4
and conferring protection against Hib challenge in lta4h /
mice, as neutralization of the PGP with RTR restored the
compromised bacterial clearance.
PGP can drive MMP-9 release from neutrophils and promote a
feed-forward system that generates more PGP and further
neutrophil recruitment59. Accordingly, we demonstrate that
PGP can drive MMP-9 release from neutrophils and observe
signiﬁcantly greater MMP-9 levels in Hib-infected lta4h /
mice—a phenotype that is lost if PGP is neutralized. In addition
to MMP-9, we demonstrated Hib-infected lta4h / to exhibit a
broader protease imbalance with an elevation in NE and
MMP-12. The augmented NE is rational, given the elevated
neutrophil numbers in lta4h / mice and the potential of PGP
to drive NE from neutrophils. More surprising was the PGP-
dependent increase in MMP-12 in Hib-infected lta4h / mice.
Neutrophils do not produce MMP-12, and it is likely that alveolar
macrophages represent the primary source in our Hib model.
PGP is unable to directly elicit the release of MMP-12 from
alveolar macrophages and one would predict that release results
from a neutrophil-alveolar macrophage cross-talk. Secondary to
the elevated neutrophilia and protease imbalance was an
augmented monocytic/macrophage inﬁltrate in the lta4h /
mice that was seemingly dependent on elastin-derived matrikines
in these mice. While mature, cross-linked elastic ﬁbres are not
chemotactic for monocytes, cryptic sequences may be
released upon proteolysis by elastolytic enzymes, such as MMP-
12 or NE. Such sequences are hydrophobic penta- and
hexapeptide repeats such as VGVAPG, which has been
demonstrated to be chemoctactic for monocytes with optimal
activity atB10 nM (refs 60–62). Furthermore, many chemotactic
elastin fragments generated in vivo are also much larger, and thus
the combined chemotactic potential of elastin-derived products
towards monocytes could be substantial11. Therefore, the absence
of LTA4H in response to a fairly innocuous challenge gives rise to
an accumulation of PGP and neutrophils and a secondary
accumulation of elastin-derived matrikines and macrophage
numbers (Supplementary Fig. 6)—thus two distinct protease–
matrikine systems are inherently linked and the implications of a
failure to degrade PGP are signiﬁcant.
Loss of LTA4H function clearly resulted in an exacerbated
PGP-driven pulmonary inﬂammation and illness in response to
Hib infection. However, the importance of the LTA4H
PGP-degrading activity, even over and above the well-heralded
LTB4-generating activity, is not unique to Hib infection, as we
also report a comparable phenotype following challenge with
S. pneumoniae. Previous interpretation of the role of LTA4H in
neutrophilic inﬂammation had not considered the unrecognized
PGP-degrading secondary activity of LTA4H and will indeed be
complicated by the opposing roles of this bifunctional enzyme.
While both 5-LO and LTA4H knockout mice exhibit reduced
inﬂammation in models of ear inﬂammation and peritonitis
relative to WT mice, the reduction is more pronounced in 5-LO
knockouts63. It is feasible that deletion of LTA4H, while
preventing LTB4 production, may promote PGP levels giving
rise to the intermediary phenotype. Furthermore, in an elastase
model of emphysema, lta4h / animals exhibited a blunted
early neutrophilic response that gave way to elevated numbers at
later time points—potentially pointing to disparate temporal roles
for the two activities of LTA4H64. The signiﬁcance of LTA4H and
its dual opposing activities in different instances will be
complicated by the availability of enzymes that generate LTA4
and PGP, the relative intra vs extracellular levels of LTA4H and
many other confounding factors. It is feasible therefore that the
relative importance of each of LTA4H’s pathways will be disease
and even patient speciﬁc.
While we demonstrate the result of PGP accumulation in a
system where it is normally degraded, it is worth considering the
implications of these studies in the context of the chronic diseases
where PGP is not efﬁciently degraded. PGP is elevated in lung
diseases such as COPD and CF, often inversely correlating with
disease severity14–18. The development of COPD is associated
with an accumulation of neutrophils and macrophages and a
protease imbalance (speciﬁcally MMPs and NE) leading to ECM
attack10–12, and there is accumulating evidence that a
protease–matrikine-mediated pathology is instrumental in the
development of diseases54. We have previously demonstrated that
cigarette smoke, a key risk factor in the development of COPD,
can speciﬁcally inhibit the aminopeptidase activity of
LTA4H18,19,65. In light of our current ﬁndings, it is likely that
the failure of LTA4H to efﬁciently degrade PGP is an
instrumental and potentially early step in this protease
imbalance and augmented neutrophil and macrophage
inﬁltrate. It is also noteworthy that H. inﬂuenzae and S.
pneumoniae are common exacerbators of COPD, and that PGP
and neutrophils/proteases have been demonstrated to spike with
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exacerbations17,66,67. One can thus envisage a scenario whereby
such a bacterial challenge leads to further PGP generation in a
setting, whereby the peptide cannot be degraded. Targeting the
PGP pathway may therefore offer therapeutic potential in chronic
neutrophilic lung diseases characterized by PGP accumulation,
and in infectious exacerbations of these diseases28,68–70.
It is important to question the signiﬁcance of these ﬁndings in
the context of therapeutic strategies that seek to inhibit LTA4H to
reduce LTB4-mediated pathologies29. There has been a signiﬁcant
pharmaceutical effort to generate LTA4H inhibitors, but despite
the development of drugs that show excellent pharmacokinetic
proﬁles, none of these compounds have shown efﬁcacy in clinical
trials. These inhibitors seem unlikely to distinguish between the
opposing activities of LTA4H and may therefore inadvertently
prevent PGP degradation with adverse effects.
In conclusion, we show for the ﬁrst time the consequences of a
failure to degrade PGP, highlighting a critical role for the
secondary anti-inﬂammatory activity of LTA4H. In response to a
relatively innocuous pulmonary challenge, accumulation of PGP
leads to an augmented neutrophilic inﬂammation and ensuing
illness, as well as a general protease imbalance that targets the
ECM and further perpetuates inﬂammation. These studies have
signiﬁcant implications for our basic understanding of LTA4H
biology, the cross-talk between protease–matrikine networks, the
role of PGP in the pathology and development of chronic lung
diseases and the design and application of LTA4H inhibitors by
pharmaceutical companies.
Methods
Haemophilus inﬂuenzae b. Hib Eagan strain was a kind gift from Professor
T. Hussell (Institute of Inﬂammation and Repair, The University of Manchester,
UK). Bacteria were cultured at 37 C in 5% CO2 in Brain Heart Infusion (BHI)
broth (OXOID, Hampshire, UK) supplemented with 10 mgml 1 of both Hemin
(Roche, West Sussex, UK) and nictinamide adenine dinucleotide (Sigma-Aldrich,
Dorset, UK) or on BHI agar (OXOID) supplemented with 4% Levinthals. Levin-
thals was made by adding 50% horse blood (TCS Biosciences, Buckingham, UK) to
BHI broth and heating to 70 C for 45min. On cooling to 50 C, 0.7mgml 1
nictinamide adenine dinucleotide was added and the supernatant was stored at
 80 C. Bacteria were cultured to an optical density (OD)600 of 0.3 (B1 109
c.f.u. ml 1) and stored at  80 C in 10% glycerol as single-use aliquots.
S. pneumoniae. S. pneumoniae (serotype 2) strain D39 (NCTC 7466, National
Collection of Type Cultures, London, UK), a kind gift from Professor T. Hussell
(Institute of Inﬂammation and Repair, The University of Manchester) was cultured
at 37 C in 5% CO2 on blood agar plates or in Todd-Hewitt broth (OXOID) sup-
plemented with 0.5% yeast extract (OXOID) (THY broth) to an OD600 of 0.4
(B1 108 c.f.u.ml 1) and stored at  80 C in 10% glycerol as single-use aliquots.
Mice. Six- to eight-week-old female BALB/c and C57BL/6 mice were purchased
from Harlan Olac Ltd (Oxon, UK). Blt1 / , on a C57BL/6 background, were
purchased from Jackson Labs (Bar Harbor, ME), and Lta4h / mice and
littermate controls were on a 129/S6 background and a gift from Dr Y.M. Shim
(University of Virginia, Charlottesville, VA). All WT 129/S6 mice referred to
within the manuscript are littermate controls of lta4h / mice. All mice were
kept in speciﬁed pathogen-free conditions and provided autoclaved food, water and
bedding. This study was carried out in accordance with the recommendations in
the Guide for the Use of Laboratory Animals of Imperial College London. All
animal procedures and care conformed strictly to the UK Home Ofﬁce Guidelines
under the Animals (Scientiﬁc Procedures) Act 1986, and the protocols were
approved by the Home Ofﬁce of Great Britain.
Lta4h / and Blt1 / mice were genotyped by PCR on genomic DNA
extracted using the Extract-N-Amp Tissue PCR Kit (Sigma-Aldrich). The WT
expression of LTA4H was detected by primers oIMR1720 (50-CGAATCCATGCT
TAAAATTGC-30) and oIMR1721 (50-GCGTTACGAACGTGAGACAA-30) to
yield a product size of 128 bp, and Lta4h / LTA4H was detected by primers
oIMR6916 (50-CTTGGGTGGAGAGGCTATTC-30) and oIMR6917 (50-AGGTGA
GATGACAGGAGATC-30) to yield a product size of 280 bp. Ampliﬁcation was
achieved by PCR (94 C for 3min435 2.5min cycles (30 s at 94 C460 s at
60 C460 s at 72 C)472 C for 2min). The BLT1 expression was detected by
primers oIMR8160 (50-ATAGCTTTGTAGTGTGGAGCATCCTGA-30),
oIMR8161 (50-TGGAAGACTTTATGCTCTTTGTTGGGA-30) and oIMR8162
(50-TGGATGTGGAATGTGTGCGAG-30) to yield a product size of 433 bp
for WT and 270 bp for mutant. Ampliﬁcation was achieved by PCR (94 C for
3min435 2.5min cycles (30 s at 94 C460 s at 64 C460 s at 72 C)472 C for
2min). Ampliﬁcation fragments were visualized on 2% agarose gels.
Mouse infection model. Mice were anaesthetized with isoﬂourane and infected
intranasally (i.n.) with 1 106 or 1 107 c.f.u. Hib or with 1 105 or 1 106 c.f.u.
S. pneumoniae in 50 ml of sterile PBS. Mice were monitored daily and weight loss
was recorded. In neutrophil depletion experiments, 129/S6 mice received
intraperitoneal (i.p.) administration of 500 mg and i.n. administration of 200mg of
anti-Ly6G (1A8, Bio X Cell, West Lebanon, NH) or control rat IgG (2A3, Bio X
Cell) the day preceding and the day of infection and culled 24 h later. In alveolar
macrophage-depletion experiments, 129/S6 mice received i.n. administration of
50 ml of control or clodronate liposomes (ClodronateLiposomes.com) 24 and 48 h
before infection and culled 24 h post infection. In some experiments, BLT-1-spe-
ciﬁc antagonist U-75302 (Cayman Chemical Company, Ann Arbor, MI) or BLT2-
speciﬁc antagonist LY2552833 (Cayman Chemical Company) or vehicle controls
were administered at a dose of 100 mg i.p. to 129/S6 mice 1 h before infection and
9 h post infection before being culled at 24 h post infection. In some experiments,
mice were each i.p. administered 500 mg of zileuton (Sigma-Aldrich) the day pre-
ceding and the day of infection and culled 24 h later. Zileuton was dissolved in a
50% solution of dimethyl sulfoxide (DMSO) (Sigma-Aldrich) in saline, with a ﬁnal
volume of 100 ml. A similar volume of DMSO was given i.p. to control mice in these
experiments. In some experiments, mice were administered i.n. 250 mg AcPGP
(BACHEM, Bubendorf, Switzerland) or control AcPGG (BACHEM) peptide 2 h
post infection and culled at 24 h. To neutralize PGP, mice were administered RTR
peptide (Anaspec peptides, Fremont, CA) at a dose of 100 mg i.n. to mice 1 and 9 h
post infection before being culled at 24 h. To neutralize elastin fragments, mice
were administered BA4 (Sigma-Aldrich) or control antibody at a dose of 50 mg i.n.
to mice on a daily basis from time of infection before being culled at day 4.
Cell recovery and isolation. Mice were administered 3mg pentobarbital and
exsanguinated via the femoral artery. Serum was isolated by centrifugation for
8min at 5,000g and frozen at –80 C until required. The lungs were then inﬂated
ﬁve times with 1.5ml PBS via an intratracheal cannula and 100 ml from each mouse
removed for enumeration of bacterial burden (see below). The remainder was
centrifuged and the supernatant stored at –80 C. The pellet was resuspended at
106 cells per millilitre in R10F (RPMI containing 10% (vol/vol) FCS, penicillin
(50Uml 1), streptomycin (50 mgml 1) and L-glutamine (2mM)) and cell via-
bility was assessed using trypan blue exclusion. Lung tissue was disrupted to a
single-cell suspension by passage through a 100-mM sieve (BD labware, New Jer-
sey). 100 ml from each mouse was again removed for enumeration of bacterial
burden and the remaining cell suspension was centrifuged for 5min at 800g and
red blood cells lysed by resuspending pellets in ACK buffer (0.15M ammonium
chloride, 1M potassium hydrogen carbonate and 0.01mM EDTA,
pH 7.2) for 3min at room temperature before centrifugation (800g for 5min) and
resuspending in R10F. Cell viability was assessed by trypan blue exclusion and cells
resuspended in R10F at 106 cells per millilitre.
Alveolar macrophages were isolated by adherence of BAL ﬂuid to plastic for 1 h
in DMEM at 37 C, 5% CO2 and shown to be 497% pure by ﬂow cytometric
analysis. To isolate bone marrow neutrophils, the femur and the tibia from both
hind legs were removed and freed of soft tissue attachments, and the extreme distal
tip of each extremity was cut off. HBSS containing 15mM EDTA and 30mM
HEPES was forced through the bone with a syringe. After dispersing cell clumps
and passage through a 100-mM sieve (BD labware), red blood cells were lysed by
resuspending pellets in ACK buffer (for 3min at room temperature) before
centrifugation (800g 5min) and washing with HBSS. The cell suspension was
centrifuged (800g, 5min, 4 C) and resuspended in RPMI. The cells were layered
onto a 72, 64, 52% Percoll gradient (Sigma-Aldrich) diluted in PBS (100%
Percoll¼ nine parts Percoll and one part 10 PBS), and centrifuged (1,500g,
30min, room temperature) without braking. The neutrophils at the 64/72%
interface were harvested and washed with 20ml RPMI. Cell viability was assessed
by trypan blue exclusion and conﬁrmed to be 490% neutrophils by ﬂow
cytometry.
Bacterial c.f.u. enumeration. BALF and lung suspension (as detailed above) were
serially diluted in sterile PBS and plated onto appropriate agar plates (Columbia
blood agar plates for S. pneumoniae, BHI agar with 4% Levinthals for Hib) and
grown overnight at 37 C with 5% CO2. Resultant colonies were counted manually.
S. pneumoniae was conﬁrmed by optochin sensitivity. Hib was conﬁrmed by no
growth on BHI agar without Levinthals.
Flow cytometry. Single-cell suspensions were stained for surface markers in PBS
containing 0.1% sodium azide and 1% BSA for 30min at 4 C and ﬁxed with 2%
paraformaldehyde. Data were acquired on a BD FACS Fortessa machine (BD
Biosystems, UK). Forward-scatter and side-scatter gates were used to exclude
debris, and dead cells were excluded using a ﬁxable near-infrared dead cell stain kit
for 633 or 635 nm excitation. Cell types were characterized by their forward- and
side-scatter proﬁles and by their phenotypes, as depicted in Table 1.
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Treatment of neutrophils with AcPGP. Pre-warmed neutrophil suspensions
(37 C, 2 106 cells per millilitre) were incubated in 1% BSA/HBSS with or without
AcPGP (0.1mgml 1; BACHEM) or IL-8 (1 mgml 1) for 15min at 37 C in 5%
CO2. The level of enzymes released in cell-free supernatant was measured by
enzyme-linked immunosorbent (ELISA)-based assays (see below).
Alveolar macrophage and neutrophil phagocytsosis assay. Alveolar macro-
phages (pre-adhered; 1 105) or bone-marrow-derived neutrophils (in suspension;
1 105) from WT and blt1 / mice were incubated with H. inﬂuenzae b
(multiplicity of infection 20:1; with 10% serum) conjugated with pHrodo dye
utilizing the pHrodo Phagocytosis Particle Labelling Kit (Invitrogen, USA) and
phagocytosis assessed by ﬂow cytometry according the manufacturer’s directions.
pHrodo is a ﬂuorogenic dye that exhibits low ﬂuorescence at neutral pH but
ﬂuoresces in acidic environments, allowing accurate measurement of the
engulfment of pHrodo-labelled bacteria into the acidic phagosome.
Alveolar macrophage- and neutrophil-killing assay. Alveolar macrophages
(pre-adhered; 5 105) or bone-marrow-derived neutrophils (in suspension;
1 106) from WT and blt1 / mice were infected with H. inﬂuenzae b
(multiplicity of infection 1:1) in RPMI with 5% serum at 37 C. After 15min,
extracellular bacteria were removed by washing 3 with ice-cold RPMI and cells
were resuspended in 300 ml RPMI/5% serum and incubated at 37 C. At 0, 30 and
60min, 100 ml samples were removed and diluted into 900 ml H2O. Cells were
allowed to lyse by standing at room temperature for 10min and were subsequently
vortexed vigorously to disperse bacteria. Samples were further diluted in H2O,
plated on BHI agar with 4% Levinthals and grown overnight at 37 C with 5% CO2.
Resultant colonies were counted and % original c.f.u. burden determined relative to
the t¼ 0-min time point.
Protease quantiﬁcation and activity. The concentration of MMP-9 in BALF and
neutrophil supernatants was measured using an ELISA, according to the manu-
facturer’s directions (R&D Systems, Minneapolis, MN). To assess MMP-9 gelati-
nolytic activity, BALF was mixed 1:1 (vol:vol) with Tris-Glycine-SDS Sample Buffer
(Life Technologies Ltd, Paisley, UK) and loaded onto 10% zymogram (gelatin) gels
(Life Technologies Ltd). Samples were subsequently electrophoresed at 125V for
90min in Tris-Glycine-SDS Running Buffer (Life Technologies Ltd). Following
electrophoresis, gels were incubated in 1 Zymogram Renaturing Buffer (Life
Technologies Ltd) for 30min at room temperatrue. To visualize the gelatinolytic
activity, the gel was incubated in 1 Zymogram Developing Buffer (Life Tech-
nologies Ltd) overnight at 37 C before staining with SimplyBlue Safestain (Life
Technologies Ltd).
The concentrations of LTA4H, NE and MMP-12 in BALF and/or neutrophil
supernatants were measured using an ELISA, according to the manufacturer’s
directions (USCN Life Science, Hubei, PRC).
PE activity assay. Twenty microlitre of BALF was incubated with a speciﬁc
substrate (2mM Benzylcarboxy-Glycine-Proline-para-Nitroaniline, ZGP-pNa;
Chem-Impex, Wood Dale, IL) at 37 C and 5% CO2 and cleavage of para-
nitroaniline (pNa) from the substrate by PE was detected using a spectro-
photometer at 410 nm.
ESI–LC/MS/MS for PGP detection. For peptide quantiﬁcation in BALF, PGP and
AcPGP were measured using a MDS Sciex (Applied Biosystems, Foster City, CA)
API-4000 spectrometer equipped with a Shimadzu HPLC (Columbia, MD). For
peptide quantiﬁcation from degradation experiments, PGP and AcPGP were
measured using a Thermo Accela Pump and Autosampler coupled to a Thermo
TSQ Quantum Access. HPLC was done using a 2.0 150-mm Jupiter 4u Proteo
column (Phenomenex, Torrance, CA) with A: 0.1% HCOOH and B: MeCNþ 0.1%
HCOOH: 0-0.5min 5% buffer B/95% buffer A, then increased over 0.5-2.5min to
100% buffer B/0% buffer A. Background was removed by ﬂushing with 100%
isopropanol/0.1% formic acid. Positive electrospray mass transitions were at
270-70, 270-116 and 270-173 for PGP and 312-140 and 312-112 of AcPGP.
PGP degradation experiments. Bronchoalveolar lavage ﬂuid (diluted 1/10 in
PBS) was incubated with 0.4mM PGP at 37 C and 5% CO2 for 2 h. Concentrations
of PGP remaining were subsequently quantiﬁed by electrospray ionization (ESI)–
liquid chromatography (LC)/mass spectrometry (MS)/MS (as discussed above) by
comparison with PGP standards. The percentage of peptide degraded was deter-
mined relative to control samples of 0.4mM PGP alone.
Measurement of free proline. Aliquots from PGP degradation experiments were
diluted 1 in 10 in PBS (to a ﬁnal volume of 250 ml). Glacial acetic acid (250 ml) was
then added, followed by 250 ml of ninhydrin solution (25mg/ml in acetic acid/6M
phosphoric acid; heated at 70 C to dissolve). The reaction mixture was heated at
100 C for 60min, allowed to cool to room temperature and the proline containing
fraction extracted with 500ml of toluene and optical density measured at 520 nm.
LTA4H epoxide hydrolase activity. 50ml of the BAL cell suspension was added to
50 ml of RPMI and treated with A23187 at a ﬁnal concentration of 2 mg/ml. 1%
DMSO was used as a control. Cells were incubated for 20minutes at 37 C, and
supernatants removed and stored at  80 C for subsequent LTB4 analysis (as
described below).
LTB4 quantiﬁcation. The actual concentration of LTB4 in the BALF and that
generated in the epoxide hydrolase activity assay (above) was assayed using an
ELISA, according to manufacturer’s directions (R&D systems) or for maximal
sensitivity/speciﬁcity using a MDS Sciex (Applied Biosystems) API-4000 spectro-
meter equipped with a Shimadzu HPLC. HPLC was done using a 2.1 100mm
Kinetex column (Phenomenex) with A: 10mM NH4OAc and B: MeCNþ 10mM
NH4OAc: 0–0.5min 5% buffer B/95% buffer A, then increased over 0.5–5min to
100% buffer B/0% buffer A. Negative electrospray mass transitions were at 335–
195, 335–151 and 335–123 for LTB4.
Table 1 | Characterization of immune cells by ﬂow cytometry.
Cell type Surface marker phenotype Monoclonal antibody conjugate Catalogue number Dilution
B cells CD19þ
CD3
CD19-FITC (BD Biosciences)
CD3-PECy7 (eBioscience)
557398
25-0031
1/100
1/200
Natural killer (NK) cells NKp46þ
CD3
NKp46-PE (eBioscience)
CD3-PECy7 (eBioscience)
12-3351
25-0031
1/200
1/200
CD4þ T cells CD4þ
CD3þ
CD4-PerCP (BD Biosciences)
CD3-PECy7 (eBioscience)
553052
25-0031
1/200
1/200
CD8þ T cells CD8þ
CD3þ
CD8-APC (BD Biosciences)
CD3-PECy7 (eBioscience)
553035
25-0031
1/200
1/200
Neutrophils Ly-6Ghigh
CD11bhigh
CD11clow
F4/80low
Ly6G-FITC (BD Biosciences)
CD11b-PerCP (eBioscience)
CD11c-APC (BD Biosciences)
F4/80-PE (eBioscience)
551460
45-0112
550261
12-4801
1/100
1/400
1/200
1/50
Alveolar macrophages CD11blow-int.
CD11chigh
F4/80high
CD11b-PerCP (eBioscience)
CD11c-APC (BD Biosciences)
F4/80-PE (eBioscience)
45-0112
550261
12-4801
1/400
1/200
1/50
Inﬂammatory monocytes/macrophages CD11bhigh
CD11clow
F4/80high
CD11b-PerCP (eBioscience)
CD11c-APC (BD Biosciences)
F4/80-PE (eBioscience)
45-0112
550261
12-4801
1/400
1/200
1/50
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Cytokine/chemokine quantiﬁcation. The levels of CXCL1/KC, CXCL2/MIP-2,
MCP-1/CCL2, C5a, Lungkine/CXCL15, TNF-a, IL-6 (Duo Set; R&D Systems) and
MCP-3/CCL7 (MyBiosource, San Diego, CA) were measured according to the
manufacturer’s instructions.
Albumin ELISA. The concentration of albumin in BALF was measured using an
ELISA, according to the manufacturer’s directions (Bethyl Laboratories, Mon-
tgomery, TX).
Lactate dehydrogenase (LDH) assay. LDH activity in BALF was assessed using
the Lactate Dehydrogenase Activity Assay Kit (Sigma-Aldrich). Equal volumes of
LDH substrate, LDH assay dye and LDH assay cofactor preparation were com-
bined and 100 ml was added to 50ml of sample. The samples were incubated at
room temperature in the dark for 30min. The reaction was stopped using 30 ml 1 N
HCl and absorbance determined using a spectrophotometer (490 nm).
Real-time PCR. Total RNA was extracted from 50 to 100mg of lung tissue
(azygous lobe) using a Qiagen RNeasy Mini Kit. Total RNA (1 mg) was reverse
transcribed into complementary DNA using a High Capacity cDNA Reverse
Transcription Kit (Life Technologies) as per the manufacturer’s instructions. Real-
time PCR reactions were performed using fast-qPCR mastermix (Life technologies)
on a Viaa-7 instrument (Life Technologies) with TaqMan primer sets for murine
ENA-78/CXCL5, MCP-1/CCL2, MCP-3/CCL7, MMP-9, MMP-12, GAPDH or
HPRT (Life Technologies), and gene expression was analysed using the change-in-
threshold DDCt method; fold changes in mRNA expression for targeted genes were
calculated relative to naive WT controls.
Statistical analysis. Statistical signiﬁcance was calculated using an unpaired
Mann–Whitney test. All P values of r0.05 (*) and r0.01 (**) were considered
signiﬁcant and are referred to as such in the text.
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